摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(+)-8-Hydroxymanzamine J

中文名称
——
中文别名
——
英文名称
(+)-8-Hydroxymanzamine J
英文别名
(1R,2R,5Z,12R,13S,16Z)-25-(8-hydroxy-9H-pyrido[3,4-b]indol-1-yl)-11,22-diazatetracyclo[11.11.2.12,22.02,12]heptacosa-5,16,25-trien-13-ol
(+)-8-Hydroxymanzamine J化学式
CAS
——
化学式
C36H46N4O2
mdl
——
分子量
566.8
InChiKey
BLGVMYSFSXUVEE-QSJPHVJZSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.5
  • 重原子数:
    42
  • 可旋转键数:
    1
  • 环数:
    7.0
  • sp3杂化的碳原子比例:
    0.53
  • 拓扑面积:
    84.4
  • 氢给体数:
    4
  • 氢受体数:
    5

文献信息

  • Methods of treating disease through the administration of a manzamine analog or derivative
    申请人:Hamann T. Mark
    公开号:US20050085554A1
    公开(公告)日:2005-04-21
    A method of treating cancer, inflammatory disease or an infectious disease or condition in a subject in need of such treatment is disclosed. The method comprises administering to a subject an effective amount of a manzamine, or a rationally modified manzamine derivative or analog or an optical isomer or racemate or tautomer thereof or a pharmaceutically acceptable salt or prodrug thereof generated through optimized fermentation of a Micromonospora sp., extraction from sponges and then modified through semisynthesis.
    本方法揭示了一种治疗癌症、炎症性疾病或感染性疾病或状况的方法,适用于需要此类治疗的受试者。该方法包括向受试者施用有效量的曼莎明、或经合理改造的曼莎明衍生物或类似物或其光学异构体或消旋体或亚式异构体或在aMicromonosporasp.经过优化发酵生成的药学上可接受的盐或前药,然后通过半合成进行修改。
  • [EN] METHODS OF TREATING DISEASE THROUGH THE ADMINISTRATION OF A MANZAMINE ANALOG OR DERIVATIVE<br/>[FR] METHODES DE TRAITEMENT DES MALADIES PAR ADMINISTRATION D'UN ANALOGUE OU D'UN DERIVE DE MANZAMINE
    申请人:UNIV MISSISSIPPI
    公开号:WO2005084157A2
    公开(公告)日:2005-09-15
    A method of treating cancer, inflammatory disease or an infectious disease or condition in a subject in need of such treatment is disclosed. The method comprises administering to a subject an effective amount of a manzamine, or a rationally modified manzamine derivative or analog or an optical isomer or racemate or tautomer thereof or a pharmaceutically acceptable salt or prodrug thereof generated through optimized fermentation of a Micromonospora sp., extraction from sponges and then modified through semisynthesis.
查看更多